Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 4 (1)

Trial Status

Recruiting3
Unknown1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07341776Phase 4Recruiting

Steroid Use in Treatment of Allergic Reactions to Food

NCT06421415RecruitingPrimary

Long Term Effect of AIT in Children

NCT04331522RecruitingPrimary

Allergen Provocations- HCA Children's Hospital

NCT03225534Unknown

Project 500 CHILD Study

Showing all 4 trials

Research Network

Activity Timeline